Figure & Data

References

Citations

Citations to this article as recorded by  

• Bacterial persisters: molecular mechanisms and therapeutic development
  Hongxia Niu, Jiaying Gu, Ying Zhang
  Signal Transduction and Targeted Therapy.2024;[Epub]     CrossRef
• Gene Regulatory Mechanism of Mycobacterium Tuberculosis during Dormancy
  Yiduo Liu, Han Li, Dejia Dai, Jiakang He, Zhengmin Liang
  Current Issues in Molecular Biology.2024; 46(6): 5825.     CrossRef
• Construction and expression of Mycobacterium tuberculosis fusion protein SHR3 and its immunogenicity analysis in combination with various adjuvants
  Zian Zhang, Lifa Xu, Xiaochun Wang, LingYun Kong, Zilun Shi, Qiangsen Zhong, Yun Xu, Jianghong Wang
  Tuberculosis.2024; 145: 102480.     CrossRef
• Enhancement of mycobacterial pathogenesis by host interferon-γ
  Huynh Tan Hop, Pao-Chi Liao, Hsin-Yi Wu
  Cellular and Molecular Life Sciences.2024;[Epub]     CrossRef
• Distribution of lineages and type II toxin-antitoxin systems among rifampin-resistant Mycobacterium Tuberculosis Isolates
  Maryam Shafipour, Abdolmajid Mohammadzadeh, Pezhman Mahmoodi, Mahdi Dehghanpour, Ezzat Allah Ghaemi, Francesca Boldrin
  PLOS ONE.2024; 19(10): e0309292.     CrossRef
• The zoonotic pathogen Wohlfahrtiimonas chitiniclastica – current findings from a clinical and genomic perspective
  Anna Kopf, Boyke Bunk, Thomas Riedel, Percy Schröttner
  BMC Microbiology.2024;[Epub]     CrossRef
• Genome wide screening to discover novel toxin–antitoxin modules in Mycobacterium indicus pranii; perspective on gene acquisition during mycobacterial evolution
  Aayush Bahl, Roopshali Rakshit, Saurabh Pandey, Deeksha Tripathi
  Biotechnology and Applied Biochemistry.2024;[Epub]     CrossRef
• PCR Development for Analysis of Some Type II Toxin–Antitoxin Systems, relJK, mazEF3, and vapBC3 Genes, in Mycobacterium tuberculosis and Mycobacterium bovis
  Maryam Shafipour, Abdolmajid Mohammadzadeh, Ezzat Allah Ghaemi, Pezhman Mahmoodi
  Current Microbiology.2024;[Epub]     CrossRef
• Multitargeting: An Alternative Approach to Tackle Multidrug Resistance in Tuberculosis
  Satakshi Hazra, Risha Hazarika, Sanjukta Patra
  Current Drug Targets.2023; 24(9): 751.     CrossRef
• Salidroside Attenuates Cisplatin-Induced Ototoxicity: An Experimental Study In Vitro and In Vivo
  Kanglun Jiang, Tan Wang, Zirui Zhao, Lei Zhou, Huaili Jiang, Na Shen, Daquan Wu, Xinsheng Huang
  Journal of Biomedical Nanotechnology.2023; 19(4): 600.     CrossRef
• The past, present and future of tuberculosis treatment
  Kefan BI, Dan CAO, Cheng DING, Shuihua LU, Hongzhou LU, Guangyu ZHANG, Wenhong ZHANG, Liang LI, Kaijin XU, Lanjuan LI, Ying ZHANG
  Journal of Zhejiang University (Medical Sciences).2022; 51(6): 657.     CrossRef
• Cellular functions of the ClpP protease impacting bacterial virulence
  Mazen E. Aljghami, Marim M. Barghash, Emily Majaesic, Vaibhav Bhandari, Walid A. Houry
  Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
• Comparative Genomic Analysis of the Human Pathogen Wohlfahrtiimonas Chitiniclastica Provides Insight Into the Identification of Antimicrobial Resistance Genotypes and Potential Virulence Traits
  Anna Kopf, Boyke Bunk, Sina M. Coldewey, Florian Gunzer, Thomas Riedel, Percy Schröttner
  Frontiers in Cellular and Infection Microbiology.2022;[Epub]     CrossRef
• Mycobacterium tuberculosis PknK Substrate Profiling Reveals Essential Transcription Terminator Protein Rho and Two-Component Response Regulators PrrA and MtrA as Novel Targets for Phosphorylation
  Vandana Malhotra, Blessing P. Okon, Akash T. Satsangi, Sumana Das, Uchenna Watson Waturuocha, Atul Vashist, Josephine E. Clark-Curtiss, Deepak Kumar Saini, Amit Singh
  Microbiology Spectrum.2022;[Epub]     CrossRef
• Transcriptional profiling of the stringent response mutant strain E. coli SR reveals enhanced robustness to large‐scale conditions
  Martin Ziegler, Julia Zieringer, Ralf Takors
  Microbial Biotechnology.2021; 14(3): 993.     CrossRef
• Persistence of Intracellular Bacterial Pathogens—With a Focus on the Metabolic Perspective
  Wolfgang Eisenreich, Thomas Rudel, Jürgen Heesemann, Werner Goebel
  Frontiers in Cellular and Infection Microbiology.2021;[Epub]     CrossRef
• Mobilome Analysis of Achromobacter spp. Isolates from Chronic and Occasional Lung Infection in Cystic Fibrosis Patients
  Laura Veschetti, Angela Sandri, Cristina Patuzzo, Paola Melotti, Giovanni Malerba, Maria M. Lleò
  Microorganisms.2021; 9(1): 130.     CrossRef
• Genome‐wide interaction screen for Mycobacterium tuberculosis ClpCP protease reveals toxin–antitoxin systems as a major substrate class
  Michal Ziemski, Julia Leodolter, Gabrielle Taylor, Anne Kerschenmeyer, Eilika Weber‐Ban
  The FEBS Journal.2021; 288(1): 99.     CrossRef
• Evaluating the Potential for Cross-Interactions of Antitoxins in Type II TA Systems
  Chih-Han Tu, Michelle Holt, Shengfeng Ruan, Christina Bourne
  Toxins.2020; 12(6): 422.     CrossRef
• Targeting Type II Toxin–Antitoxin Systems as Antibacterial Strategies
  Marcin Równicki, Robert Lasek, Joanna Trylska, Dariusz Bartosik
  Toxins.2020; 12(9): 568.     CrossRef
• Persister cell development among Enterobacteriaceae, Pseudomonadaceae, Mycobacteriaceae and Staphylococcaceae biotypes: A review
  Somanath Behera, Smaranika Pattnaik
  Biocatalysis and Agricultural Biotechnology.2019; 22: 101401.     CrossRef
• Toxins targeting transfer RNAs: Translation inhibition by bacterial toxin–antitoxin systems
  Lauren R. Walling, J. Scott Butler
  WIREs RNA.2019;[Epub]     CrossRef
• The relevance of persisters in tuberculosis drug discovery
  Soma Mandal, Samuel Njikan, Anuradha Kumar, Julie V. Early, Tanya Parish
  Microbiology .2019; 165(5): 492.     CrossRef
• The Toxin-Antitoxin MazEF Drives Staphylococcus aureus Biofilm Formation, Antibiotic Tolerance, and Chronic Infection
  Dongzhu Ma, Jonathan B. Mandell, Niles P. Donegan, Ambrose L. Cheung, Wanyan Ma, Scott Rothenberger, Robert M. Q. Shanks, Anthony R. Richardson, Kenneth L. Urish, Jon P. Boyle
  mBio.2019;[Epub]     CrossRef
• Toxin–antitoxin systems shows variability among Mycobacterium tuberculosis lineages
  J S Solano-Gutierrez, C Pino, J Robledo
  FEMS Microbiology Letters.2019;[Epub]     CrossRef
• Epidemiological, clinical and mechanistic perspectives of tuberculosis in older people
  Wing W. Yew, Takashi Yoshiyama, Chi C. Leung, Denise P. Chan
  Respirology.2018; 23(6): 567.     CrossRef
• RE: “DIETARY INTAKE OF ANTIOXIDANT VITAMINS AND CAROTENOIDS AND RISK OF DEVELOPING ACTIVE TUBERCULOSIS IN A PROSPECTIVE POPULATION-BASED COHORT”
  Wing Wai Yew, Denise P Chan, Chi Chiu Leung, Ying Zhang
  American Journal of Epidemiology.2018; 187(7): 1570.     CrossRef
• System-Wide Analysis Unravels the Differential Regulation and In Vivo Essentiality of Virulence-Associated Proteins B and C Toxin-Antitoxin Systems of Mycobacterium tuberculosis
  Sakshi Agarwal, Prabhakar Tiwari, Amar Deep, Saqib Kidwai, Shamba Gupta, Krishan Gopal Thakur, Ramandeep Singh
  The Journal of Infectious Diseases.2018; 217(11): 1809.     CrossRef
• Does oxidative stress contribute to adverse outcomes in HIV-associated TB?
  Wing-Wai Yew, Denise P Chan, Amit Singhal, Ying Zhang, Shui-Shan Lee
  Journal of Antimicrobial Chemotherapy.2018; 73(5): 1117.     CrossRef
• Co-expression network analysis of toxin-antitoxin loci in Mycobacterium tuberculosis reveals key modulators of cellular stress
  Amita Gupta, Balaji Venkataraman, Madavan Vasudevan, Kiran Gopinath Bankar
  Scientific Reports.2017;[Epub]     CrossRef
• The endobacterium of an arbuscular mycorrhizal fungus modulates the expression of its toxin–antitoxin systems during the life cycle of its host
  Alessandra Salvioli di Fossalunga, Justine Lipuma, Francesco Venice, Laurence Dupont, Paola Bonfante
  The ISME Journal.2017; 11(10): 2394.     CrossRef
• Oxidative stress and TB outcomes in patients with diabetes mellitus?
  Wing Wai Yew, Chi Chiu Leung, Ying Zhang
  Journal of Antimicrobial Chemotherapy.2017; 72(6): 1552.     CrossRef
• Early diagnosis and effective treatment regimens are the keys to tackle antimicrobial resistance in tuberculosis (TB): A report from Euroscicon's international TB Summit 2016
  Arundhati Maitra, Tengku Karmila Kamil, Monisha Shaik, Cynthia Amaning Danquah, Alina Chrzastek, Sanjib Bhakta
  Virulence.2017; 8(6): 1005.     CrossRef
• Identification of four type II toxin-antitoxin systems in Actinobacillus pleuropneumoniae
  Chengkun Zheng, Xigong Zhao, Ting Zeng, Manman Cao, Jiali Xu, Guolin Shi, Jinquan Li, Huanchun Chen, Weicheng Bei
  FEMS Microbiology Letters.2017;[Epub]     CrossRef
• Emerging drugs and drug targets against tuberculosis
  Nzungize Lambert, Abualgasim Elgaili Abdalla, Xiangke Duan, Jianping Xie
  Journal of Drug Targeting.2017; 25(4): 296.     CrossRef
• Wake me when it’s over – Bacterial toxin–antitoxin proteins and induced dormancy
  Nathan P Coussens, Dayle A Daines
  Experimental Biology and Medicine.2016; 241(12): 1332.     CrossRef
• Emerging Roles of Toxin-Antitoxin Modules in Bacterial Pathogenesis
  Barbara Kędzierska, Finbarr Hayes
  Molecules.2016; 21(6): 790.     CrossRef
• Phenotypic Heterogeneity in Mycobacterium tuberculosis
  Neeraj Dhar, John McKinney, Giulia Manina, William R. Jacobs Jr., Helen McShane, Valerie Mizrahi, Ian M. Orme
  Microbiology Spectrum.2016;[Epub]     CrossRef
• tRNAs taking charge
  Jonathan W. Cruz, Nancy A. Woychik, Peter Sebo
  Pathogens and Disease.2016; 74(2): ftv117.     CrossRef